The new crown epidemic is about to complete its third year. Data shows that the number of infected people in the world exceeds 600 million, and the cumulative death toll exceeds 6.56 million. The aftermath of the new crown is being discussed and paid more and more attention. On October 10, the Journal of the American Medical Association published a large-scale global study led by WHO online, which is regarded as the most comprehensive analysis of the sequelae of the new crown since the epidemic. The study pooled data on 1.2 million people with symptomatic new crown infections in 22 countries. The model estimates that 6.2% of new crown infections will be in 2020 and 2021, and more than 74,000 people will report at least three months after their first infection. COVID-19 sequelae. "The new crown is not only a respiratory disease, but also affects many tissues and organs of the human body, involving the central nervous system, peripheral nervous system, gastrointestinal tract,...
Professional manufacturer of Rifampicin and Rifamycin Derivatives. Rifamycin S Sodium, Rifamycin S, Rifampicin, Rifandine, Rifaximin, Rifampin producer supplier exporter